Search clinical trials for: VAL-083 (Dianhydrogalactitol)

Total 2419 results

London North West Healthcare NHS Trust

Unknown

Effect of Standing, Lying and Stockings on Blood Bio-markers (v.1)

Chronic Venous Insufficiency

United Kingdom
Hiroshima University
NewBio Enterprise Co., ltd.

Completed

Effect of the Extract of the Flour Fermented With Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose

Prediabetes

Japan
Tel-Aviv Sourasky Medical Center
SciGen, Israel

Unknown

Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients

HIV

Israel
Wuerzburg University Hospital
University Hospital, Bonn; University Hospital, Aachen

Recruiting

Conventional vs. Video-Assisted Laryngoscopy for Perioperative Endotracheal Intubation (COVALENT)

Endotracheal Intubation

Germany
Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-237

Covid19

Japan, Thailand
Vaxcyte, Inc.

Active, not recruiting

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Pneumococcal Vaccines

United States
Takeda

Available

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Colorectal Cancer
Padagis LLC

Completed

Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Assiut University

Completed

Ultrasonographic Assessment of Lung Recruitment Maneuvers in Children Undergoing Lengthy Microsurgery Operations (RM)

Intraoperative Complications

Egypt
Shanghai Kechow Pharma, Inc.

Terminated

Phase I Study of HL-085 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Healthy Subjects

United Kingdom
Achaogen, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789

Healthy Volunteers

Australia
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Alzheimer's Disease

United States, Korea, Republic of
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Relapsing Remitting Multiple Sclerosis
Chr Hansen

Completed

Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population

Inflammation

Ireland
Sir Run Run Shaw Hospital
Hangzhou Neoantigen Therapeutics Co., Ltd.

Recruiting

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms

Digestive System Neoplasms

China
Vedea Healthware BV
Elisabeth-TweeSteden Ziekenhuis; Jeroen Bosch Ziekenhuis; Health Holland; Oogziekenhuis... and other collaborators

Recruiting

Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT) (VAT)

Amblyopia | Amblyopia, Anisometropic | Amblyopia Strabismic

Netherlands
Sheng Hu
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Malignant Pleural Effusion | Malignant Peritoneal Effusion

China
University of Michigan

Recruiting

Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients

Spine Surgery | Wounds Vac

United States
University of British Columbia

Enrolling by invitation

Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly

Frail Elderly Syndrome

Canada
Hill-Rom

Completed

AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries

Pressure Ulcer

United States
Vical

Completed

A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma

Metastatic Melanoma

United States
Ashok Tuteja
United States Department of Defense

Unknown

Probiotic (Visbiome) for Gulf War Illness

Gulf War Illness

United States
InnaVirVax

Completed

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

HIV-1 Infection

France
VSL Pharmaceuticals

Terminated

The Effect of a Probiotic on Hepatic Steatosis

Fatty Liver

United States
Photocure

Completed

Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne

Acne

Canada
Michael Hoelscher
Leibniz Institute for Natural Product Research and Infection Biology Hans...

Completed

Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment

Lung Diseases | Mycobacterium Infections | Tuberculosis | Tuberculosis, Pulmonary | Bacterial Infections Respiratory

Netherlands
AO GENERIUM

Completed

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

Hereditary Angioedema

Russian Federation
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)

Plaque Psoriasis
Valent Technologies, LLC

Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Ewing Sarcoma | Medulloblastoma | Neuroblastoma | Solid Tumors | Rhabdomyosarcoma | Hepatoblastoma

United States
Assiut University

Not yet recruiting

VAC and Conventional Dressing in the Healing Process of Necrotizing Fasciitis

Necrotizing Fascitis

Egypt
Health Institutes of Turkey
TC Erciyes University

Completed

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)

COVID-19 Vaccine

Turkey
Centro de Estudios en Infectogía Pediatrica

Withdrawn

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

COVID-19

Colombia
University of Leicester

Terminated

Measuring sVAP-1 as a Predictor of Pregnancy Problems

Pregnancy Complications

United Kingdom
Gamaleya Research Institute of Epidemiology and...
Government of the city of Moscow; CRO: Crocus Medical BV

Unknown

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (RESIST)

Covid19 Prevention

Russian Federation
National Health Research Institutes, Taiwan

Completed

A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine

Enterovirus Infection

Taiwan
University of North Carolina, Chapel Hill
Johns Hopkins University; Novartis Pharmaceuticals

Completed

Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis

Cystic Fibrosis

United States
St. Joseph's Healthcare Hamilton
Queen's University, Kingston, Ontario

Completed

Transcranial Magnetic Stimulation in Bipolar Depression (TMS)

Bipolar Affective Disorder

Canada
University of California, Berkeley
Carl Zeiss Meditec, Inc.

Completed

Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle (CZV_PAL1)

Presbyopia

United States
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.

Recruiting

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Non Hodgkin Lymphoma

China
BeiGene
SpringWorks Therapeutics, Inc.

Recruiting

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Solid Tumor, Adult

Australia, United States
AbbVie

Completed

ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors

Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Undifferentiated Pleomorphic Sarcoma | Carcinoma of the Breast

United States, France, Spain
Rao Dermatology

Recruiting

Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin

Healthy Skin

United States
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Recruiting

Phase Ib/II Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-hodgkin's Lymphoma

China
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Recruiting

A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Primary Central Nervous System Lymphoma | Secondary Central Nervous System Lymphoma

China
Carnegie Mellon University
Johns Hopkins Bloomberg School of Public Health; University of Michigan; University... and other collaborators

Enrolling by invitation

The Study Estimates the Longitudinal Impact of a Gamified Health Education App on Students' Health and Learning Outcomes (DVx-SCHOOL)

COVID-19 | Infectious Disease | Health Behavior | Physical Inactivity | Nutrition, Healthy | Habit, Diet

India
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Type 2 Diabetes

Korea, Republic of
Arcutis Biotherapeutics, Inc.

Completed

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Psoriasis | Plaque Psoriasis

United States, Canada, Dominican Republic
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Type2 Diabetes Mellitus

Korea, Republic of
Orlucent, Inc

Unknown

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Nevus | Dysplasia; Epithelial

United States

Search clinical trials for: VAL-083 (Dianhydrogalactitol)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations